iSpecimen

iSpecimen Net Debt per Share

The Net Debt per Share of iSpecimen (ISPC) as of Oct 16, 2026 is -0.68 USD. In the previous year, Net Debt per Share was -0.16 USD — a change of 322.16% (lower).

Net Debt per Share

-0.68USD

YoY

322.16%

Last updated:

Net Debt per Share of iSpecimen is 2025 -0.68 USD. Net Debt per Share of iSpecimen was 2024 -0.16 USD. It decreases by 322.16% lower compared to the previous year.

The iSpecimen Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2018
0.60 USD
Jan 1, 2019
1.08 USD
Jan 1, 2020
1.24 USD
Jan 1, 2021
-2.49 USD
Jan 1, 2022
-1.55 USD
Jan 1, 2023
-0.49 USD
Jan 1, 2024
-0.16 USD
Jan 1, 2025
-0.68 USD
The iSpecimen Net Debt per Share history
YEARNet Debt per ShareYoY
-0.68USD+322.16%
-0.16USD-67.43%
-0.49USD-68.20%
-1.55USD-37.81%
-2.49USD-301.43%
1.24USD+14.56%
1.08USD+80.50%
0.60USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

iSpecimen Stock analysis

What does iSpecimen do? iSpecimen Inc. is a healthcare company based in Lexington, Massachusetts, operating in the Health Care sector. The company went public on June 17, 2021, with ticker ISPC and ISIN US45032V2079. It employs 75 full-time staff members. iSpecimen provides a digital marketplace platform for the procurement of human biospecimens, connecting healthcare providers with biospecimens to researchers in biopharmaceutical, in vitro diagnostic (IVD), and academic or government institutions. The platform streamlines the biospecimen acquisition process, offering a centralized online solution for buyers and sellers. It integrates de-identified healthcare data from supply partners, supporting administrative and reporting functions for all users. The iSpecimen Marketplace is structured around four key areas: search, workflow, data, and administration and reporting. The company’s website is www.ispecimen.com. iSpecimen does not disclose specific financial figures or detailed product names beyond the marketplace platform, and it does not provide information about acquisitions, founding year, or key personnel. The company focuses on accelerating medical discovery through efficient biospecimen access. iSpecimen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about iSpecimen stock

Net Debt per Share of iSpecimen is -0.68 USD in 2025.

Net Debt per Share of iSpecimen changed from -0.16 USD to -0.68 USD, representing a 322.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share iSpecimen since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — iSpecimen

All Key Metrics — iSpecimen